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Abstract
Toxoplasma gondii establishes a chronic infection by forming cysts preferentially in the brain. This chronic infection is one of
the most common parasitic infections in humans and can be reactivated to develop life-threatening toxoplasmic
encephalitis in immunocompromised patients. Host-pathogen interactions during the chronic infection include growth of
the cysts and their removal by both natural rupture and elimination by the immune system. Analyzing these interactions is
important for understanding the pathogenesis of this common infection. We developed a differential equation framework
of cyst growth and employed Akaike Information Criteria (AIC) to determine the growth and removal functions that best
describe the distribution of cyst sizes measured from the brains of chronically infected mice. The AIC strongly support
models in which T. gondii cysts grow at a constant rate such that the per capita growth rate of the parasite is inversely
proportional to the number of parasites within a cyst, suggesting finely-regulated asynchronous replication of the parasites.
Our analyses were also able to reject the models where cyst removal rate increases linearly or quadratically in association
with increase in cyst size. The modeling and analysis framework may provide a useful tool for understanding the
pathogenesis of infections with other cyst producing parasites.
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Introduction
Toxoplasma gondii, an obligate intracellular protozoan parasite, is
an important foodborne pathogen that can cause various diseases
including lymphadenitis and congenital infection of the fetuses in
humans. Infection occurs through ingestion of food or water
contaminated with cysts or oocysts. The acute stage of infection is
characterized by proliferation of tachyzoites in various nucleated
cells. IFN-c-mediated immune responses limit tachyzoite prolifera-
tion [1–3] and the parasite establishes a chronic infection by form-
ing cysts containing bradyzoites, primarily in the brain (Figure 1).
Chronic infection with T. gondii is one of the most common
parasitic infections in humans. It is estimated that 500 million to 2
billion people worldwide are infected with the parasite [4,5].
During the chronic stage of infection, bradyzoites slowly
replicate within the cysts and cyst sizes increase in response. In
immunocompromised individuals such as those with AIDS and
organ transplants, cysts can rupture resulting in release of
bradyzoites, conversion of bradyzoites into tachyzoites, and
proliferation of tachyzoites, which can cause life-threatening
toxoplasmic encephalitis [6,7] (Figure 1). Even in immunocompe-
tent host, T. gondii cysts occasionally rupture during the chronic
stage of infection [8]. In these cases, tachyzoite growth is
controlled by the host’s immune response, but the parasite is
most likely able to form small numbers of new cysts (Figure 1).
Such natural rupture of cysts and the formation of new cysts are
thought to result in a wide range of T. gondii cyst sizes observed in
the brains of chronically infected mice.
There is currently only limited information on the immune
responses to the cyst stage of T. gondii [9,10]. It was generally
considered that T. gondii cysts cannot be recognized by the
immune system. However, our recent study revealed that the
CD8z T cells have the capability to remove tissue cysts from the
brains of infected mice [9]. Marked decreases in cyst numbers
occur during the T cell-mediated anti-cyst immune responses,
suggesting that the immunity-mediated removal of the cysts can
prevent formation of new cysts (Figure 1). Therefore, host-
pathogen interactions during the chronic stage of T. gondii
infection appear to have two distinct processes. One is a natural
rupture of tissue cysts that can result in formation of new cysts.
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The other is the T cell-mediated cyst removal not associated with
formation of new cysts. In order to better understand the dynamics
of host-pathogen interactions during chronic T. gondii infection, in
the present study we developed a set of biologically based models
of cyst growth and removal including both natural rupture and
immunity-mediated removal of tissue cysts and compared these
models with actual data on distribution of sizes of T. gondii cysts
obtained from the brains of chronically infected mice.
Methods
Measurements of T. gondii Cysts Formed in the Brains of
Mice
Previous studies by Hooshyar et al. [11] provided limited
snapshots of the cyst size distributions in the brains of infected
mice during the period of 2–4 months after infection. Typically,
sizes of T. gondii cysts are viewed in terms of diameter. However,
volume is biologically a more appropriate measure to indicate the
size of cysts since it is expected to be proportional to the number of
bradyzoites in a cyst. Hooshyar et al. assumed the shape of a cyst
was ellipsoidal and measured the two diameters of the ellipsoid
[11]. Based on their data, the mean volumes of cysts at 2, 3,
and 4 months after infection were 54:15+35:18 (103mm3),
139:15+175:05 (103mm3), and 107:97+67:32 (103mm3), respec-
tively. The number of cysts examined was 17 for each time point.
There is a significant difference in the cyst volume between
months 2 and 3 (t~{1:963, pv0:05), 2 and 4 (t~{2:922,
pv0:05), but not 3 and 4 (t~0:0685, not significant). These
studies support the assumption that cyst volume reaches a steady
state distribution within 4 months after infection.
In order to have a larger data set of cysts in the steady state
during the chronic stage of infection, we measured sizes of over
200 cysts of T. gondii in the brains of mice at 6 months after
infection. Female Swiss-Webster mice (Taconic, Germantown,
NY) were infected intraperitoneally with 10 cysts of the ME49
strain (a type II strain) as previously described in [12]. T. gondii has
three predominant clonal genotypes (types I, II, and III) [13–15].
Type II constitutes a majority of clinical cases of toxoplasmosis and
asymptomatic infections in humans in North America and Europe
[13,15,16]. Six months later, the brain of each of four mice was
triturated in 1 ml of PBS [9]. Mouse care and experimental
procedures were performed in accordance with established
institutional guidance and approved protocols from the Institu-
tional Animal Care and Use Committee. Four to six aliquots
(20 microliters each) of each brain suspension were applied to
microscopic examination using a Nikon Eclipse 90i microscope
and a photograph was taken on each T. gondii cyst detected at
6400 magnification with a Nikon DS-Ri1 digital camera.
Photographs of 50–56 cysts from each brain, a total of 213 cysts
from four mice, were recorded (see Figure 2 for a photograph of a
typical cyst). We measured the diameter of each cyst from two
different angles using NIS Elements BR analysis 3.2 software
(Figure 3; see also supplemental data). We calculated the volumes
of each cyst using the two measured diameters by assuming an
Figure 1. Schematic life cycle of T. gondii.
doi:10.1371/journal.pcbi.1003283.g001
Author Summary
A large portion of people worldwide are chronically
infected with T. gondii. Chronic infection with this parasite
is characterized by formation of tissue cysts. Bradyzoites
slowly replicate within cysts during the chronic stage of
infection leading to a corresponding increase in cyst size.
Cysts occasionally rupture and release bradyzoites that
invade nearby host cells and convert into tachyzoites
which can quickly proliferate. Tissue cysts can also be
targeted by immune T cells and phagocytes for removal.
We developed a differential equation model to investigate
the cumulative effects of unknown growth and removal
functions on the cyst-size distribution. We then used the
AIC to select models that best fit experimental cyst size
distribution data obtained from the brains of chronically
infected mice. The results suggest that the within-cyst
growth of bradyzoites is finely-regulated asynchronous
such that the per capita growth rate is inversely
proportional to the number of bradyzoites. While it may
be surprising that the bradyzoites replicate in a way
analogous to a factory producing a product, there may be
factors such as nutrient availability, resource allocation,
immune response, and other stress factors that may limit
replication in cysts.
Regulated Growth of Toxoplasma gondii Cyst
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ellipsoidal shape: v~1=6pdLd
2
S , where dL is the larger diameter
and dS is the smaller diameter.
Modeling Cyst Formation and Growth
There have been several attempts to understand the biology of
Toxoplasma gondii infection through mathematical modeling
[17,18], however, none of these previous efforts have tried to
model the growth and distribution of cysts as a function of their
volume. Because in this study we are solely interested in the
distribution of cyst volumes, we do not explicitly model population
of free bradyzoites, tachyzoites, and uninfected target cells and,
instead, simply assume new cysts are being formed at some rate
B(t). See Figure 4 for a schematic of the within-host system and
Table 1 for definitions of the functions used in our model.
Biologically B(t) represents the rate at which uninfected target
cells become infected by free parasites and begin forming
intracellular cysts. Following [19], we model the growth of these
cysts using a partial differential equation (PDE) structured by both
time t and cyst volume v. Specifically,
LY (t,v)
Lt
z
L
Lv
g(v)Y (t,v)ð Þ~{r(v)Y (t,v) ð1Þ
where Y (t,v) is the density of bradyzoite cysts of volume v at time
t, g(v) is the cyst growth rate, i.e. the rate at which the bradyzoite
population grows within a cyst, and r(v) is the cyst removal rate,
i.e. the sum of the rate at which encysted cells are either cleared by
the immune response or through natural cyst bursting.
Conceptually, the PDE defined in Equation (1) describes how
the density of cysts of size v at time t develops over time. For
example, the first term on the left hand side of Equation (1)
describes the ‘movement’ of cysts of size v along the time variable
t. Since movement along the time axis is constant, we can think of
the cysts as being carried along a conveyer belt along the t
variable. The second term describes how growth ‘stretches’ or
‘compresses’ the distribution of Y (v,t) with cyst growth. For
example, if we are considering the density of cysts in a region
where g(v) is increasing with v, then the density of cysts Y (t,v) will
be stretched out along the v variable as larger cysts move more
quickly along the axis. In contrast, if g(v) is decreasing with v then
Y (t,v) will be compressed along v as smaller cysts ‘catch up’ with
the larger cysts. Finally, if g(v) is constant with respect to v, similar
to with the time variable, the density of cysts Y (v,t) can be
envisioned as moving along the v axis on conveyer belt. The
removal term on the right hand side of Equation (1) describes the
rate at which the cyst density Y (t,v) is being ‘siphoned off’ via the
removal process. If the removal rate r(v) decreases/increases with
v, then larger cysts are removed at a lower/higher rate. If r(v) is
constant with respect to v, then the total density of cysts of a
particular age (i.e. Y (t)~
Ð vmax
v0
Y (t,v)dv) will decline exponentially
with time t.
Although these two cyst removal processes differ in that bursting
can ultimately leads to the production of new cysts while immune
response clearance does not, their effects on the relative
distribution of cysts as a function of volume are indistinguishable
and, hence, combined in Equation (1). Biologically, both g(v) and
r(v) likely vary with the immune response state of the host.
However, since we are focusing on the steady state of the system
where the immune response state of the host is constant, we do not
explicitly model this dependency. For simplicity, we assume that
all new cysts have an initial volume v0. Based on our definition of
B(t) as the rate at which new cysts are formed, according to [20]
Figure 2. Example of photograph of a cyst from our
experiment. Most of the cysts observed took on similar nearly circular
cross section projections.
doi:10.1371/journal.pcbi.1003283.g002
Figure 3. Relationship between the two measured diameters
for each cyst. The effective diameter is computed as the geometric
mean of the two measured diameters: d~
ffiffiffiffiffiffiffiffiffi
d1d2
p
.
doi:10.1371/journal.pcbi.1003283.g003
Figure 4. Chronic infection diagram of cyst-volume distribu-
tion model. Parasites infect healthy cells and begin replicating,
causing the volume of the cyst to increase. The parasites burst at some
rate and release new parasites into the system which are capable of
infecting new healthy cells.
doi:10.1371/journal.pcbi.1003283.g004
Regulated Growth of Toxoplasma gondii Cyst
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the boundary condition for Equation (1) satisfies the equality,
B(t)~g(v0)Y (t,v0): ð2Þ
The general solution of Equation (1) can be obtained using the
method of characteristics [21]. First, an inverse function must be
determined to find the correspondence between size and time.
Depending on a cysts initial volume, v0, the current volume, v, can
be determined by some function that depends on the elapsed time
since infection. This function, v{1(t; t0) is the solution to
v(a)~
Ð a
0
g(v)dvzv0, where g(v) is growth rate. From equation
(2), the equation for B(t) is the boundary condition. Then, the
general solution is:
Y (v,t)~
B(t)
g(v0)
e
{
ðt
t
r(v{1(a; t))zg(v{1(a; t))
 
da
, vvv{1(t; 0)
Y0(v
{1(0))e
{
ðt
0
r(v{1(a; t))zg(v{1(a; t))
 
da
, v§v{1(t; 0)
8>>><
>>>:
ð3Þ
where B(t) is the boundary condition (inflow of all new cysts into
the system), v{1 is the characteristic curve through the time-size
domain that is defined by solving the inverse equation above, t is
the initial time we wish to model. See Calsina and Saldana for a
complete derivation [21].
Steady-State Solution
Although Equation (1) can be explicitly solved as a function of
time (e.g. see [21]), here we focus solely on the steady state
solution. Letting Ŷ represent the steady state solution of Equation
(1), that is,
LY
Lt
DŶ ~0. Under this condition, Equation (1) simplifies
to the following ordinary differential equation
dŶ
dv
~{f (v)Ŷ ð4Þ
where f (v) is a combined function of the cyst growth g(v) and
removal r(v) functions:
f (v)~
r(v)zg’(v)
g(v)
: ð5Þ
Note that g’(v) is the derivative of g(v) with respect to v. Equation
(4) has a general solution of
Ŷ (v)~Ŷ0 exp {
ðv
v0
f (z)dz
" #
ð6Þ
where Ŷ0 represents the steady state density of newly formed cysts
and satisfies the boundary condition defined in equation (2) with
B(t)~B̂~g(v0)Ŷ0.
Because the combined function f (v) is a function of both g(v)
and r(v) the first parameters of growth and removal functions, g0
and r0 respectively, cannot be uniquely identified. Instead, they
can be estimated only as ratios of one another, i.e. r0=g0, in this
setting.
Fitting Models to the Cyst Volume Estimates
Our data on cyst volume represents a random sample from the
larger cyst population, in order to fit our models to this data we
generate a probability density function y(v) from our steady state
solution. We investigate the steady state solution in Equation (6)
under several different forms of growth and removal functions; see
the function definitions in Table 2. We divide cyst density by the
total cyst population size, ŶT~
Ð vmax
v0
Ŷ (v)dv to get a probability
density function for cyst size. Specifically,
y v ~l
 ~ Ŷ v ~l
 
Ŷ T ~l
 ~ exp f v ~l
 h iÐ vmax
v0
exp f z ~l
 h idz , ð7Þ
where~l represents the parameters of a given combined function f
(e.g. r0=g0 or r0=g0 and r1). Using this probability density function,
it follows that the negative log-likelihood L of a particular model
and parameter set ~l given a random sample of n observed cyst
volumes ~V~fV1,V2, . . . Vng is simply,
Table 1. Functions and their definitions.
Function Biological Description
B(t) The rate at which uninfected target cells are becoming infected at time t, leading to the formation of new cysts with volume v0.
B̂ The rate at which uninfected target cells are becoming infected at steady state.
g(v) Cyst volume growth rate. Equal to the rate at which bradyzoite population is increasing within a cyst.
g9(v) First derivative of the cyst growth function g(v) with respect to v.
r(v) Cyst removal via both immune response clearance and cyst bursting.
v0 Volume of newly formed cysts.
vmax Maximum possible cyst volume.
Y(t,v) Absolute density of host cells infected with cysts of volume v at time t.
Ŷ (v) Absolute density of host cells infected with cysts of volume v at steady state.
ŶT Total density of infected host cells and equal to
Ð vmax
v0
Ŷ (v)dv.
y(v) Relative density of host cells infected with cysts of volume v at steady state and equal to Ŷv=ŶT
doi:10.1371/journal.pcbi.1003283.t001
ð3Þ
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PLOS Computational Biology | www.ploscompbiol.org 4 November 2013 | Volume 9 | Issue 11 | e1003283
L(~V j~l)~{
Xn
i~0
ln ŷ Vi ~l
  
~{
Xn
i~1
ln(Ŷ (Vi))
 !
zn ln
ðvmax
v0
Ŷ (v)dv
 ! ð8Þ
For each model in Table 2 we estimated the corresponding
model parameters~l by minimizing L based on the observed data
~V using the NMinimize routine in Mathematica 8.1. The minimal
L value and the total number of independent parameters were
used to calculate the AIC value for each model. AIC and
parameter estimates are also presented in Table 2.
Results
We measured two diameters on each of 213 cysts detected in the
brains of 4 mice at 6 months after infection in order to have a
larger size of data on volume of cysts in the steady stage during the
chronic stage of infection. Distributions of diameters measured
and volume of cysts calculated from the diameters by assuming
Table 2. Model selection results.
Index Growth g(v) Removal r(v) AIC DAIC
r0
g0
r1 vmax
1 g0 r0 1915.88 0.33 0.03 N/A N/A
2 g0 r0v 1990.32 74.77 0.0004 N/A N/A
3 g0 r0v
2 2064.06 148.51 1026 N/A N/A
4 g0 r0
v
1zv
1916.21 0.66 0.03 N/A N/A
5 g0
r0
v2
1zv2
1915.55 0.0 0.03 N/A N/A
6 g0 r0 1zr1vð Þ 1917.88 2.33 0.0017 0.0 N/A
7 g0 r0
v
r1zv
1917.87 2.32 0.03 0.07 N/A
8 g0
r0
v2
r1zv2
1917.12 1.57 0.03 8.74 N/A
9 g0v r0 2812.87 897.32 0.07 N/A N/A
10 g0v r0v 2487.93 572.38 0.002 N/A N/A
11 g0v r0v
2 2467.12 551.56 2.261025 N/A N/A
12 g0v r0
v
1zv
2670.9 755.35 0.13 N/A N/A
13 g0v
r0
v2
1zv2
2670.1 754.55 0.13 N/A N/A
14 g0v r0(1zr1v) 2489.93 574.38 8.07610
27 2180.13 N/A
15 g0v r0
v
r1zv
2489.93 574.38 2.706106 1.536109 N/A
16 g0v
r0
v2
r1zv2
2469.12 553.56 3.016106 1.3561011 N/A
17 g0v(1{
v
vmax
) r0 2794.98 879.43 0.045 N/A 1862.92
18 g0v(1{
v
vmax
) r0v 2487.92 572.36 0.0035 N/A 936.57
19 g0v(1{
v
vmax
) r0v
2 2436.17 520.62 0.000025 N/A 277.77
20 g0v(1{
v
vmax
) r0
v
1zv
2687.36 771.81 0.082 N/A 2308.9
21 g0v(1{
v
vmax
) r0
v2
1zv2
2749.31 833.76 0.045 N/A 1956.8
22 g0v(1{
v
vmax
) r0 1zr1vð Þ 2460.84 545.28 0.000068 39.015 278.72
23 g0v(1{
v
vmax
) r0
v
r1zv
2460.51 544.95 3.746106 1.416109 277.77
24 g0v(1{
v
vmax
) r0
v2
r1zv2
2510.48 594.93 0.60 1565.63 1138.84
The AIC is calculated using AIC~2k{2 ln(L), where k is the number of parameters and L is the maximum likelihood for the model. Models 1–8 correspond to a
constant growth function. Models 9–16 correspond to a linear growth function. Models 17–24 correspond to a logistic growth function. The removal functions in
models 4, 12, and 20 are known as the one-parameter type II function. The removal functions in models 5, 13, and 21 are known as the one-parameter type III function.
The removal functions in models 7, 15, and 23 are known as the two-parameter type II function. The removal functions in models 8, 16, and 24 are known as the two-
parameter type III function. See Figure 6 for schematic representations of different growth and removal functions. For models 1–5 and models 9–13, k~1 and the
parameter is r0=g0 . For models 6–8 and models 14–16, k~2 and the parameters are r0=g0 and r1 . For models 17–21, k~2 and the parameters are r0=g0 and vmax . For
models 22–24, k~3 and the parameters are r0=g0 , r1 , and vmax .
doi:10.1371/journal.pcbi.1003283.t002
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that cysts are in an ellipsoidal shape are shown in Figure 5. While
the probability distribution on the diameter scale (Figures 5 (c) and
(d)) is unimodal, the probability distribution on the volume scale
(Figures 5 (a) and (b)) does not show modality. This difference is
due to nonlinear transform between volume and diameter [22].
See the Methods section for calculation of the volume.
We developed a differential equation model to investigate the
cumulative effects of unknown growth and removal functions on
the cyst- size distribution. As a means for model selection, the
Akaike information criterion (AIC) [23] was used to evaluate and
compare different models; see Table 2. Based on information
entropy, AIC is an estimate of the relative information lost for a
given model. The AIC value of a model is calculated using its
negative log-likelihood at the maximum-likelihood estimation
(MLE) parameters and the number of parameters. Therefore,
AIC provides a trade-off between a model’s complexity and its
goodness of fit. The DAIC of a given model is the difference
between the lowest observed AIC value and the AIC value of the
model [24].
We explored three different growth functions and eight different
removal functions. A schematic illustrations of these functions are
shown in Figure 6. More detailed descriptions of the function
formalities can be seen in Holling [25]. To determine the cyst
growth model that can fit best to the experimental data, we
explore three different hypotheses as follows. The first hypothesis is
that cysts grow at a constant rate i.e. g(v)~g0, such that the cyst
volume increases linearly with time (indices 1–8 in Table 2).
Because bradyzoite number within a cyst increases with its size,
this hypothesis corresponds to a per capita growth rate of
bradyzoites that is inversely proportional to the number of
bradyzoite, implying that bradyzoite replication is finely regulated
and asynchronous within the cyst. The second hypothesis is that
the cyst volume increases exponentially with time g(v)~g0v
(indices 9–16 in Table 2). This corresponds to a constant per
capita growth rate of within-cyst bradyzoites, implying that
bradyzoites replicate independently of each other within the cyst.
The third hypothesis is that the cyst volume grows logistically with
time i.e. g(v)~g0v(1{v=vmax) (indices 17–24 in Table 2). This
hypothesis implies that bradyzoite replication is regulated within
the cyst in a simple density dependent manner in which the per
capita growth rate declines linearly with cyst volume. The AIC
scores indicate that hypotheses two and three are not supported by
the data. Therefore, we focused on various removal functions
under hypothesis one. In regard to the cyst removal rate, models
with constant (index 1), one-parameter type II (index 4), two-
parameter linear (index 6), two-parameter type II (index 7), and
two-parameter type III (index 8) functions all fell within 2.5 AIC
units of the best model (index 5), which is a model with a one-
parameter type III function. We can, however, clearly reject
models where cyst removal rate increases linearly (index 2) or
quadratically (index 3) in association with increases in cyst volume.
Comparison between probability distributions of the experimental
data and the models using constant growth function (indices 1–8)
in Figure 5.
Discussion
We have developed a mathematical framework to select the
most appropriate mathematical descriptions for the growth and
removal processes of T. gondii cysts through parameter fitting of
experimental data obtained from the brains of chronically infected
mice. Population growth often satisfies a linear or logistic growth
function [26]. However, experimental data here supports a
constant growth rate model, i.e., g(v)~g0. We calculated the
volumes of cysts by assuming that cysts are in an ellipsoidal shape.
We also performed the same analysis by assuming that cysts are in
a spherical shape using the effective diameter (data not shown). In
both cases, we reached the same conclusion. We assumed the cyst
volume is proportional to the number of bradyzoites within the
cyst. Therefore, a constant volume growth rate indicates that the
number of parasites within the cyst increases linearly over time
and the per capita growth of bradyzoites is inversely proportional
to the number of parasites within a cyst. This probably suggests
that bradyzoites do not replicate synchronously but each
bradyzoite divide independently to produce a single new
bradyzoite within a certain time interval. For example, a cyst
may start with a given number of bradyzoites and a single new
bradyzoite may be formed through replication every few hours.
This is a contrast to tachyzoites of T. gondii or merozoites of
malaria parasite. The tachyzoites and merozoites are the acute
stage form of these parasites and they proliferate quickly after
invading into host cells. On the other hand, tissue cysts of T. gondii
are formed in the chronic stage of infection and the major purpose
of cysts is most likely to persist within host cells, rather than
proliferate. Therefore, it appears that tachyzoites and bradyzoites
within cysts are under distinct regulatory mechanisms to control
their proliferation. While it may be surprising that the bradyzoites
replicate in a way analogous to a factory producing a product,
there may be factors such as nutrient availability, immune
response, and other stress factors that may limit their replication.
Figure 6. Schematic representations of the growth (left) and
removal (right) functions.
doi:10.1371/journal.pcbi.1003283.g006
Figure 5. Comparison of probability distributions between
experimental data and model selection results using the
constant growth function: one-parameter models (indices 1–
5) and two-parameter models (indices 6–8). Panels (a) and (b)
show the distributions against volumes and panels (c) and (d) show the
distributions against effective diameters. See Figure 3 for the definition
of the effective diameter. See Table 2 and Figure 6 for definitions of
different models.
doi:10.1371/journal.pcbi.1003283.g005
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Based on the analyses on cyst growth described above, we
performed parameter fitting of various removal functions with the
constant growth rate. The best model was a one-parameter type
III function; however several other removal functions performed
similarly well and are indistinguishable from one another. Based
on the AIC criteria, performances of the following functions
(constant, type II, type III, and type III with two parameters) are
indistinguishable for the constant growth rate model. Thus, the
current data cannot distinguish between several removal functions.
However, our analyses were able to reject models where cyst
removal rate increases linearly or quadratically with increases in
cyst volume. This result would suggest that removal of cysts is the
outcome of a complex of multiple biological mechanisms.
In this study, we considered two removal processes: natural
rupture and immune-mediated removal. Natural rupture of cysts
may not occur simply based on the volume of cysts. It may also
depend on cell-types of cyst-containing host cells and location of
cysts in the brain. It has been shown that T. gondii can form cysts in
both glial cells and neurons [27–29]. Removal of cysts by immune
T cells and phagocytes could be independent of the sizes of the
cysts contained in the infected host cells. To determine the specific
removal function that fits best in experimental data, we would
need to collect data on the transient dynamics and conduct
corresponding studies. Moreover, the current study on steady state
can only determine the ratio between the parameters r0 and g0.
Transient data are also needed to estimate these parameters
separately.
Recent studies suggested possible contributions of chronic
infection with T. gondii with important diseases such as cryptogenic
epilepsy and Alzheimer’s disease [30,31]. Thus, it is crucial to
understand the mechanisms of host-pathogens interactions in the
brain during the chronic stage of infection with this parasite for
defining the pathogenesis of this common infection. The present
study provided valuable information that may improve our
understanding in this aspect. This study also demonstrated a
power of mathematical modeling to provide the information that
will be difficult to obtain directly from biological studies. In the
present study, we obtained the data at only one time point of the
chronic stage of infection. Having the data from multiple time
points including the acute stage of infection and larger samples
numbers at each time points will assist in understanding of
dynamics of cyst growth and removal during the course of
infection with T. gondii. These data will also assist in better
understanding of the roles of natural rupture of cysts and immune
response-mediated removal of cysts in the pathogenesis of cerebral
infection with the parasite.
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